Alpha 2.0
Login Register
» Articles » PMID: 35041759

Dupilumab-associated Head and Neck Dermatitis is Associated with Elevated Pretreatment Serum Malassezia-specific IgE: a Multicentre, Prospective Cohort Study

Overview
Journal Br J Dermatol
Publisher Oxford University Press
Specialty Dermatology
Date 2022 Jan 18
PMID 35041759
Authors
Emily Kozera
Thomas Stewart
Kyra Gill
Mae Anne De La Vega
John W Frew
Affiliations
Soon will be listed here.
Abstract

Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia-specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.

Citing Articles

Combined Dupilumab and Allergen-Specific Immunotherapy in Severe Refractory Atopic Dermatitis.

Kim J, Boo J, Jang H, Jung Y, Kim J, Zhang K Allergy Asthma Immunol Res. 2024; 16(6):682-689.

PMID: 39622691 PMC: 11621481. DOI: 10.4168/aair.2024.16.6.682.

Fungal Head and Neck Dermatitis: Current Understanding and Management.

Chong A, Navarro-Trivino F, Su M, Park C Clin Rev Allergy Immunol. 2024; 66(3):363-375.

PMID: 39031274 PMC: 11422441. DOI: 10.1007/s12016-024-09000-7.

Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells.

Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine J, Pilz M Nat Commun. 2024; 15(1):2839.

PMID: 38565563 PMC: 10987549. DOI: 10.1038/s41467-024-46540-0.

Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis.

Umemoto N, Kakurai M, Matsumoto T, Mizuno K, Cho O, Sugita T Microorganisms. 2024; 12(1).

PMID: 38276210 PMC: 10820602. DOI: 10.3390/microorganisms12010224.

Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors.

Kim R, Lam M, Abuabara K, Simpson E, Drucker A Am J Clin Dermatol. 2024; 25(2):179-193.

PMID: 38216802 DOI: 10.1007/s40257-023-00837-w.

References
1.
Darabi K, Grim Hostetler S, Bechtel M, Zirwas M . The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol. 2008; 60(1):125-36. DOI: 10.1016/j.jaad.2008.07.058. View
2.
de Wijs L, Nguyen N, Kunkeler A, Nijsten T, Damman J, Hijnen D . Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series. Br J Dermatol. 2019; 183(4):745-749. PMC: 7586932. DOI: 10.1111/bjd.18730. View
3.
Jo C, Finstad A, Georgakopoulos J, Piguet V, Yeung J, Drucker A . Facial and neck erythema associated with dupilumab treatment: A systematic review. J Am Acad Dermatol. 2021; 84(5):1339-1347. DOI: 10.1016/j.jaad.2021.01.012. View
4.
de Beer F, Bakker D, Haeck I, Ariens L, Van der Schaft J, van Dijk M . Dupilumab facial redness: Positive effect of itraconazole. JAAD Case Rep. 2019; 5(10):888-891. PMC: 6818397. DOI: 10.1016/j.jdcr.2019.07.020. View
5.
Muzumdar S, Zubkov M, Waldman R, DeWane M, Wu R, Grant-Kels J . Characterizing dupilumab facial redness in children and adolescents: A single-institution retrospective chart review. J Am Acad Dermatol. 2020; 83(5):1520-1521. DOI: 10.1016/j.jaad.2020.06.1003. View